ArticleNPJ precision oncology2026

CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophages.

Ik-Hwan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.